SEC Form 4 · accession 0001209191-15-085761
Kura Oncology, Inc. · KURA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Malley
Director
Period of report
Nov 10, 2015
Accepted (ET)
Dec 17, 2015 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Nov 10, 2015 | P | 50,000 | $8.00 | A | 89,557 | I | By Mossrock Capital, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Malley serves as President of Mossrock Capital, LLC and has sole voting and investment power over these shares.